Skip to Content Skip to Content

Health Sciences

Reset All Filters
2001 Results
Penn Medicine Study Reveals Why Almost Half of At-Risk Patients Opt Out of Comprehensive Multiplex Cancer Screening

Penn Medicine Study Reveals Why Almost Half of At-Risk Patients Opt Out of Comprehensive Multiplex Cancer Screening

Some at-risk patients opted out of comprehensive cancer gene screening when presented with the opportunity to be tested for the presence of genes linked to various cancers, according to a recent study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and the 

Katie Delach

Penn-Michigan State Team Develops Novel Gene Therapy for Achromatopsia

Penn-Michigan State Team Develops Novel Gene Therapy for Achromatopsia

Researchers from the University of Pennsylvania and Michigan State University presented new preclinical data this week that evaluates the efficacy of a gene therapy treatment for achromatopsia, a rare inherited retinal disease that involves cone cells. The disease affects humans as well as dogs.

Katherine Unger Baillie

Off-Label Use of Device to Prevent Stroke in A-Fib Patients is Prevalent and Potentially Dangerous, According to Penn Medicine Study

Off-Label Use of Device to Prevent Stroke in A-Fib Patients is Prevalent and Potentially Dangerous, According to Penn Medicine Study

The Lariat device, which has been cleared by the U.S. Food and Drug Administration (FDA) for soft tissue approximation (placement of a suture) during surgical procedures, is associated with a significant incidence of death and urgent cardiac surgery during its frequent off-label use to prevent stroke in patients with the irregular heartbeat known as atrial fibrillation.

Anna Duerr

Penn Study Indicates that Gene Therapy Efficacy for LCA is Dynamic: Improvement is Followed by Decline in Vision

Penn Study Indicates that Gene Therapy Efficacy for LCA is Dynamic: Improvement is Followed by Decline in Vision

Gene therapy for Leber congenital amaurosis (LCA), an inherited disorder that causes loss of night- and day-vision starting in childhood, improved patients’ eyesight within weeks of treatment in a clinical trial of 15 children and adults at the Scheie Eye Institute at the Perelman School of Medicine at the University of Pennsylvania.

Lee-Ann Donegan

Penn Medicine Researchers Receive $7.5 Million to Expand HIV Gene Therapy Work

Penn Medicine Researchers Receive $7.5 Million to Expand HIV Gene Therapy Work

Researchers from the Perelman School of Medicine and the Penn Center for AIDS Research (CFAR) have been awarded $7.5 million over five years from the National Institutes of Health to initiate a multi-project HIV study investigating a new gene therapy approach to render immune cells of HIV positive patients resistant to the virus.

Steve Graff

NIH Awards $8 Million Renewal to Penn Medicine's Center of Excellence in Environmental Toxicology

NIH Awards $8 Million Renewal to Penn Medicine's Center of Excellence in Environmental Toxicology

The National Institutes of Environmental Health Sciences (NIEHS), part of the National Institutes of Health (NIH), has renewed its funding to the Center of Excellence in Environmental Toxicology (CEET), at the University of Pennsylvania’s Perelman School of Medicine, for the next five years.

Karen Kreeger